OD tablets T20 containing S-1 Taiho

OD tablets T20 containing S-1 Taiho, from Okayama Taiho Pharmaceutical (YJ code: 4229101F1050, standard: 20mg x 1 tablet (equivalent to tegafur)), is a combination chemotherapy drug with tegafur, gimeracil, and oteracil potassium. It is prescribed for various advanced cancers, including gastric, colorectal, pancreatic, and head and neck cancers, aiming to boost antitumor effects and mitigate gastrointestinal toxicities.